Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the recipient of a significant decrease in short interest in May. As of May 15th, there was short interest totaling 39,752 shares, a decrease of 86.0% from the April 30th total of 283,034 shares. Based on an average daily trading volume, of 1,382,455 shares, the short-interest ratio is presently 0.0 days. Currently, 9.4% of the shares of the company are sold short.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings cut shares of Akanda from a “sell (d-)” rating to a “sell (e+)” rating in a report on Monday, May 18th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has a consensus rating of “Sell”.
Read Our Latest Stock Report on AKAN
Akanda Stock Down 9.2%
Akanda Company Profile
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Featured Stories
- Five stocks we like better than Akanda
- Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders?
- The Food Delivery War Just Entered Its Final Phase
- Bath & Body Works Stock Surged Despite Falling Sales—Here’s Why
- Dick’s Sporting Goods Isn’t Done Winning Yet
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
